Evidence level: Emerging (six Phase I/II randomized controlled trials were conducted between 2001 and 2006, enrolling over 900 participants in total
Many insurance companies are pulling back on GLP-1 coverage Meanwhile, many insurers, including some state Medicaid programs, are limiting or even dropping coverage for weight-loss drugs because of cost
View Trial Details Santoro N, Epperson CN, Mathews SB
Going forward, keep only one concentration in your refrigerator at a time to eliminate this risk entirely
Marcin Chwistek of the Fox Chase Cancer Center in Philadelphia said at an ASCO press briefing
The elevated B12 appears to be a consequence of disease activity, likely resulting from increased production of B12-binding proteins by tumor cells or from liver involvement in the cancer process